The aim of the Comprehensive Surgery is to publish original research articles of the highest scientific and clinical value at the international level in all surgical fields. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
Prognostic factors and survival of breast cancer in patients over 40 years of age
Aims: Breast cancer is the cancer with the highest incidence and mortality in women. There are differences in prognosis and survival between women over and under the age of 40. In this article, we aimed to examine breast cancer prognostic factors and survival results in people over the age of 40.
Methods: 1187 patients aged 40 and over who underwent surgery at the Ondokuz Mayıs University Department of General Surgery between August 2005 and April 2019 and whose data were accessible were retrospectively examined. Data were obtained from the hospital automation system, the Ministry of Health’s online database, hospital archives, patients, and/or their relatives. They were classified separately in terms of type of surgery, axillary metastasis status (according to radiological status if axilla surgery is not performed), type of axilla surgery performed, pathological tumor size, number of pathological lymph nodes, pathological stage, lymphovascular and perineural invasion status, hormone receptor positivity, C-erb B2 and Ki-67 status, neoadjuvant treatment status, and molecular subgroup. Variables were analyzed individually for recurrence, mortality, and survival. Results found to be significant were subjected to multivariate analysis testing. Statistical significance was accepted as p<0.05.
Results: As a result of multivariate analysis performed by excluding data that disrupted homogeneous distribution, perineural invasion, lymphovascular invasion, grade, and progesterone receptor status were determined to be independent prognostic factors in terms of recurrence. Lymphovascular invasion and progesterone receptor status were found to be independent prognostic factors for mortality.
Conclusion: A lot of studies have been conducted, and criteria have been determined for breast cancer prognosis and survival. In our results, lymphovascular invasion and progesterone receptor status were found to be independent prognostic markers for both recurrence and mortality. More reliable results can be obtained with prospective study analyses.

1. WHO. Estimated age-standardized incidence and mortality rates (World)in 2020, females, ages 40+ (excl. NMSC) 2020.
2. Trayes KP, Cokenakes SEH. Breast cancer treatment. Am Fam Physician.2021;104(2):171-178.
3. Tesch ME, Partridge AH. Treatment of breast cancer in young adults.Am Soc Clin Oncol Educ Book. 2022;42:11-12.
4. Avci O, Tacar SY, Seber ES, Yetisyigit T. Breast cancer in young andvery young women; is age related to outcome? J Cancer Res Ther.2021;17(6):1322-1327.
5. Tarlan M, Khazaei S, Madani SH, Saleh E. Prognostic factors for cancer-specific survival in 220 patients with breast cancer: a single center experience.Cancer Rep. 2023;6(1):e1675.
6. Gao T, Shao F. Risk factors and prognostic factors for inflammatorybreast cancer with bone metastasis: a population-based study. J OrthopSurg. 2021;29(2):23094990211000144.
7. Mohamed RF, Abdelhameed DH, Mohamed MA. Combination of anatomicaland biological factors to predict disease-free survival in breast cancer. JCO GlobOncol. 2023;9:e2200269.
8. Chen M, Liu D, Chen W, et al. Impact of different modules of 21-geneassay in early breast cancer patients. Front Endocrinol. 2021;12:759338.
9. Lee JY, Lim SH, Lee MY, et al. Impact on survival of regular postoperativesurveillance for patients with early breast cancer. Cancer Res Treat.2015;47(4):765-773.
10. Tarighati E, Keivan H, Mahani H. A review of prognostic and predictivebiomarkers in breast cancer. Clin Exp Med. 2023;23(1):1-16.
11. Baranova A, Krasnoselskyi M, Starikov V, et al. Triple-negative breastcancer: current treatment strategies and factors of negative prognosis. JMed Life. 2022;15(2):153-161.
12. Su F, Chao J, Liu P, et al. Prognostic models for breast cancer: basedon logistics regression and Hybrid Bayesian Network. BMC Med InformDecis Mak. 2023;23(1):120.
13. Phung MT, Tin Tin S, Elwood JM. Prognostic models for breast cancer:a systematic review. BMC Cancer. 2019;19(1):230.
14. Makower D, Lin J, Xue X, Sparano JA. Lymphovascular invasion, race,and the 21-gene recurrence score in early estrogen receptor-positivebreast cancer. NPJ Breast Cancer. 2021;7(1):20.
15. Liu G, Kong X, Dai Q, Cheng H, Wang J, Gao J, et al. Clinical featuresand prognoses of patients with breast cancer who underwent surgery.JAMA Netw Open. 2023;6(8):e2331078.
16. Houvenaeghel G, Cohen M, Classe JM, et al. Lymphovascular invasionhas a significant prognostic impact in patients with early breast cancer,results from a large, national, multicenter, retrospective cohort study.ESMO Open. 2021;6(6):100316.
17. Lee SJ, Go J, Ahn BS, et al. Lymphovascular invasion is an independentprognostic factor in breast cancer irrespective of axillary nodemetastasis and molecular subtypes. Front Oncol. 2023;13:1269971.
18. Akrami M, Meshksar A, Ghoddusi JM, et al. Prognostic role oflymphovascular invasion in patients with early breast cancer. Indian JSurg Oncol. 2021;12(4):671-677.
19. Horwitz KB, Sartorius CA. 90 years of progesterone: progesterone andprogesterone receptors in breast cancer: past, present, future. J Mol Endocrinol.2020;65(1):T49-T63.
20. Li Z, Wei H, Li S, Wu P, Mao X. The role of progesterone receptors inbreast cancer. Drug Des Devel Ther. 2022;16:305-314.
21. Dowsett M, Allred C, Knox J, et al. Relationship between quantitativeestrogen and progesterone receptor expression and human epidermalgrowth factor receptor 2 (HER-2) status with recurrence in the Arimidex,Tamoxifen, alone or in combination trial. J Clin Oncol. 2008;26(7):1059-1065.
22. Shiino S, Ball G, Syed BM, et al. Prognostic significance of receptorexpression discordance between primary and recurrent breast cancers:a meta-analysis. Breast Cancer Res Treat. 2022;191(1):1-14.
23. Hosoya K, Wakahara M, Ikeda K, Umekita Y. Perineural invasionpredicts unfavorable prognosis in patients with invasive breast cancer.Cancer Diagn Progn. 2023;3(2):208-214.
24. Narayan P, Flynn J, Zhang Z, et al. Perineural invasion as a riskfactor for locoregional recurrence of invasive breast cancer. Sci Rep.2021;11(1):12781.
Volume 2, Issue 1, 2024
Page : 6-11